Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 4370323)

Published in Atherosclerosis on December 05, 1974

Authors

A Chait, A Onitiri, A Nicoll, E Rabaya, J Davies, B Lewis

Articles citing this

Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest (1984) 1.33

Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest (1988) 1.13

The effect of dietary carbohydrate and fat on the activities of some enzymes responsible for glycerolipid synthesis in rat liver. Biochem J (1978) 0.94

Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest (1996) 0.88

Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians. J Clin Invest (1990) 0.87

Effect of dietary fat saturation on plasma lipoproteins and high density lipoprotein metabolism of the rhesus monkey. J Clin Invest (1987) 0.81

Lipoprotein lipase activity in the tissues of guinea pigs exposed to different dietary fats from conception to three months of age. Biochem J (1978) 0.80

Interaction between marginal zinc and high fat supply on lipid metabolism and growth of weanling rats. Lipids (2011) 0.78

Hypothesis into theory--the development of aetiological concepts of ischaemic heart disease: a review. J R Soc Med (1978) 0.75

A Moderate Zinc Deficiency Does Not Alter Lipid and Fatty Acid Composition in the Liver of Weanling Rats Fed Diets Rich in Cocoa Butter or Safflower Oil. J Nutr Metab (2017) 0.75

Articles by these authors

Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet (1995) 21.03

Transposition of R factor genes to bacteriophage lambda. Proc Natl Acad Sci U S A (1975) 9.28

Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene (1983) 8.79

Plasmid-determined resistance to antimicrobial agents. Annu Rev Microbiol (1978) 8.35

Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69

Mechanisms of antibiotic resistance in bacteria. Annu Rev Biochem (1973) 7.08

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04

Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02

Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature (1991) 6.17

The problems of drug-resistant pathogenic bacteria. R factors: biochemical mechanisms of resistance to aminoglycoside antibiotics. Ann N Y Acad Sci (1971) 5.52

Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci U S A (1973) 5.20

Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) (1987) 5.01

Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor. Biochemistry (1971) 5.01

"Infectious" transplantation tolerance. Science (1993) 4.98

Transposition of an antibiotic resistance element in mycobacteria. Nature (1990) 4.85

The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75

Expression of a transposable antibiotic resistance element in Saccharomyces. Nature (1980) 4.66

Antibiotic inhibitors of the bacterial ribosome. Bacteriol Rev (1968) 4.56

Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. BMJ (1996) 4.52

Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol Pharmacol (1965) 4.45

Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44

Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA (2001) 4.30

Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J Bacteriol (1996) 3.98

A distinctive class of integron in the Vibrio cholerae genome. Science (1998) 3.86

Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety. Biochemistry (1972) 3.56

Aminoglycoside antibiotics: inactivation by phosphorylation in Escherichia coli carrying R factors. J Bacteriol (1969) 3.52

On the evolution of Tn21-like multiresistance transposons: sequence analysis of the gene (aacC1) for gentamicin acetyltransferase-3-I(AAC(3)-I), another member of the Tn21-based expression cassette. Mol Gen Genet (1989) 3.46

Appropriate responses to bioterrorist threats. BMJ (2001) 3.34

The isolation and partial characterization of a new restriction endonuclease from Providencia stuartii. Nucleic Acids Res (1976) 3.30

R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics. FEBS Lett (1971) 3.28

Horizontal gene transfer and the origin of species: lessons from bacteria. Trends Microbiol (2000) 3.24

Structural relationships among Rhizobium meliloti symbiotic promoters. Cell (1983) 3.23

Genetic mapping of the regulator and operator genes of the lac operon. J Mol Biol (1968) 3.19

The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10

Enzymatic Adenylylation of Streptomycin and Spectinomycin by R-Factor-Resistant Escherichia coli. Infect Immun (1970) 3.02

Phenotypic suppression and misreading Saccharomyces cerevisiae. Nature (1979) 3.01

An SNP map of human chromosome 22. Nature (2000) 2.99

Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest (1993) 2.89

MMR vaccination and autism 1998. BMJ (1998) 2.89

Resistance of Haemophilus influenzae to trimethoprim. Br Med J (1972) 2.89

Gene transfer between distantly related bacteria. Annu Rev Genet (1991) 2.88

Interaction between transcription factors Sp1 and YY1. Nature (1993) 2.87

A placental clock controlling the length of human pregnancy. Nat Med (1995) 2.86

Large scale identification of genes involved in cell surface biosynthesis and architecture in Saccharomyces cerevisiae. Genetics (1997) 2.81

Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81

The evolutionary history of chromosomal super-integrons provides an ancestry for multiresistant integrons. Proc Natl Acad Sci U S A (2001) 2.77

Cytogenetic analysis of a segment of the Y chromosome of Drosophila melanogaster. Genetics (1984) 2.75

The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region, Tanzania. AIDS (1992) 2.70

Mechanism of inhibition of eukaryotic protein synthesis by trichothecene fungal toxins. Proc Natl Acad Sci U S A (1974) 2.67

Inhibition of protein synthesis by spectinomycin. Science (1965) 2.54

Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest (1984) 2.53

Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin. Antimicrob Agents Chemother (1978) 2.53

Myths in medicine. Immunisation. BMJ (1994) 2.52

Nasal acquisition of Staphylococcus aureus in a subdivided and mechanically ventilated ward: endemic prevalence of a single staphylococcal strain. J Hyg (Lond) (1970) 2.48

Enzymatic inactivation of streptomycin by R factor-resistant Escherichia coli. Nature (1968) 2.45

Antibiotic inhibition of group I ribozyme function. Nature (1991) 2.44

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol (2001) 2.42

The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42

The genetics of bacterial ribosomes. Annu Rev Genet (1972) 2.41

Antenatal detection of HIV: national surveillance and unlinked anonymous survey. BMJ (2001) 2.41

Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2000) 2.41

Cimetidine and HDL cholesterol. Lancet (1983) 2.40

Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. The effect of drug concentration. J Biol Chem (1968) 2.38

Enzymatic acetylation as a means of determining serum aminoglycoside concentrations. Antimicrob Agents Chemother (1973) 2.37

The British Paediatric Surveillance Unit--a pioneering method for investigating the less common disorders of childhood. Report of a seminar held in June 1995. Child Care Health Dev (1998) 2.32

Increased rates of illness and death from asthma in Canada. CMAJ (1987) 2.31

A new selective agent for eukaryotic cloning vectors. Am J Trop Med Hyg (1980) 2.28

Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis (1975) 2.27

Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26

Synaptic transmission between individual pyramidal neurons of the rat visual cortex in vitro. J Neurosci (1991) 2.26

Effective dose from cone beam CT examinations in dentistry. Br J Radiol (2008) 2.25

Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County. Am J Prev Med (1998) 2.23

Plasmid-medicated aminoglycoside phosphotransferase of broad substrate range that phosphorylates amikacin. Antimicrob Agents Chemother (1977) 2.22

Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19

Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J (2001) 2.16

Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16

Contraindications to whooping-cough immunisation--myths or realities? Lancet (1985) 2.13

CFTR biomarkers: time for promotion to surrogate end-point. Eur Respir J (2012) 2.11

Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 2.10

Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob Agents Chemother (2000) 2.09

Spinal interneurone excitation by conformationally restricted analogues of L-glutamic acid. Nature (1974) 2.09

2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation. Neurosci Lett (1981) 2.08

Microcloning reveals a high frequency of repetitive sequences characteristic of chromosome 4 and the beta-heterochromatin of Drosophila melanogaster. Proc Natl Acad Sci U S A (1988) 2.06

Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development (1997) 2.05

Detection of antigen-antibody binding events with the atomic force microscope. Biochemistry (1997) 2.05

Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05

Mode of action of thiolutin, an inhibitor of macromolecular synthesis in Saccharomyces cerevisiae. Antimicrob Agents Chemother (1973) 2.04

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest (1986) 2.01

Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut (1994) 1.97

Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96

Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J (1991) 1.96

Bacterial vaginosis: a public health review. BJOG (2001) 1.95

A study of iterative type II polyketide synthases, using bacterial genes cloned from soil DNA: a means to access and use genes from uncultured microorganisms. J Bacteriol (1997) 1.95

Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95

Effect of spectinomycin on polypeptide synthesis in extracts of Escherichia coli. J Mol Biol (1967) 1.93

Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill (2010) 1.90

Trichodermin resistance--mutation affecting eukaryotic ribosomes. Nature (1974) 1.90